Currently submitted to: JMIR mHealth and uHealth
Date Submitted: Oct 4, 2024
Open Peer Review Period: Oct 18, 2024 - Dec 13, 2024
(currently open for review)
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Clinical Impact of Personalized Physician’s Education and Remote Feedback via a Digital Platform on Diabetes Management: a Randomized Controlled Trial
ABSTRACT
Background:
The Digital Education platform, DoctorviceⓇ (iKooB Inc., Seoul, South Korea), offers both physicians' face-to-face education and remote glucose monitoring, which is expected to be effective for personalized diabetes care.
Objective:
To evaluate the effectiveness of the digital education platform for diabetes care and compare cases where both face-to-face education and remote monitoring were provided with cases where only education was provided.
Methods:
Sixty-six patients with type 2 diabetes mellitus who visited the Diabetes Center of Seoul St. Mary’s Hospital were enrolled in this randomized clinical study. Participants were aged ≥19 years and had hemoglobin A1C (HbA1C) levels of 7.5–9.5%. Of the 66 participants, 26 in the intervention group and 30 in the control group were analyzed, excluding 10 who dropped out of the study. In the intervention group, physicians used the digital education platform to provide face-to-face education at enrollment and at the 3- and 6-month visits, along with remote monitoring during the first 3 months of the 6-month study period. The control group received conventional outpatient education. The primary endpoint was the change in the HbA1c levels.
Results:
The baseline HbA1c levels were 8.3±0.6% in the intervention group and 8.0±0.5% in the control group. At the 3-month follow-up, HbA1c decreased by 0.5% to 7.8±0.9% (P=.010) in the intervention group and by 0.2% to 7.8±0.7% in the control group. HbA1c levels significantly improved during the first 3 months with both face-to-face education and remote glucose monitoring; however, HbA1c tended to increase without the remote monitoring service during the 3 to 6-month follow-up in the intervention group. Subgroup analysis indicated that the effect of reducing HbA1c was greater for patients with baseline HbA1c levels≥8.0%, those aged≥65 years, smokers, drinkers, and those with obesity in the intervention group.
Conclusions:
The digital education platform for personalized diabetes management appears beneficial for glycemic control in type 2 diabetes mellitus. It was especially effective when physicians provided personalized face-to-face education and remote feedback together. Clinical Trial: KCT0007953
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.